Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Adrenalectomy
Primary Purpose
Pain Management, Nerve Block, Laparoscopic Adrenalectomy
Status
Terminated
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
single-injection QLB(quadratus lumborum block)
Placebo control
Sponsored by
About this trial
This is an interventional supportive care trial for Pain Management
Eligibility Criteria
Inclusion Criteria:
- Age 18-70 yrs
- American Society of Anesthesiologists physical statusⅠ-Ⅲ
- Undergo laparoscopic adrenalectomy
- Informed consent
Exclusion Criteria:
- A known allergy to the drugs being used
- Coagulopathy, on anticoagulants
- Analgesics intake, history of substance abuse
- Participating in the investigation of another experimental agent
- Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)
Sites / Locations
- Peking Union Medical College Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
single-injection QLB(quadratus lumborum block)
Placebo control
Arm Description
Single-injection of QLB with local anesthetic is given preoperatively
Single-injection of QLB with NS is given preoperatively
Outcomes
Primary Outcome Measures
pain numeric rating scale (NRS, 0-10)pain score at activity at 12 hours after surgery
Secondary Outcome Measures
The pain scores at rest determined by the numeric rating scale (NRS, 0-10)
incidence of postoperative nausea and vomiting (PONV)
ambulation time
time of restart anal exhaust
Postoperative length of hospital stay
patient's satisfaction with anesthesia and analgesia
use the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia and analgesia
The pain scores at activity determined by the numeric rating scale (NRS, 0-10)
Full Information
NCT ID
NCT03844477
First Posted
February 15, 2019
Last Updated
September 2, 2019
Sponsor
Peking Union Medical College Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03844477
Brief Title
Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Adrenalectomy
Official Title
Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Adrenalectomy
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Terminated
Why Stopped
We change the study protocal
Study Start Date
February 16, 2019 (Actual)
Primary Completion Date
May 1, 2019 (Actual)
Study Completion Date
May 15, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Peking Union Medical College Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This prospective, randomized ,control study aims to compare the analgesic effect,quality of recovery, length of hospital stay ,et al. between single-injection QLB(quadratus lumborum block)+general anesthesia (GA) and general anesthesia (GA) alone in patients undergoing laparoscopic adrenalectomy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain Management, Nerve Block, Laparoscopic Adrenalectomy
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
25 (Actual)
8. Arms, Groups, and Interventions
Arm Title
single-injection QLB(quadratus lumborum block)
Arm Type
Experimental
Arm Description
Single-injection of QLB with local anesthetic is given preoperatively
Arm Title
Placebo control
Arm Type
Placebo Comparator
Arm Description
Single-injection of QLB with NS is given preoperatively
Intervention Type
Procedure
Intervention Name(s)
single-injection QLB(quadratus lumborum block)
Intervention Description
Inject 0.4ml/kg 0.5% ropivacaine between quadratus lumborum and psoas major without continuous local infusion
Device: Ultrasound Scanner The curved (C1-5) probe of Ultrasound Scanner is used for scan
Device: PAJUNK StimuLong Drug: single dose ropivacaine 0.4ml/kg 0.5% ropivacaine given immediately after the correct position of the tip of the needle has been verified.
Intervention Type
Procedure
Intervention Name(s)
Placebo control
Intervention Description
Inject 0.4ml/kg saline between quadratus lumborum and psoas major without continuous local infusion
Device: Ultrasound Scanner The curved (C1-5) probe of Ultrasound Scanner is used for scan
Device: PAJUNK StimuLong Drug: single dose 0.4ml/kg 0.9% NS. given immediately after the correct position of the tip of the needle has been verified.
Primary Outcome Measure Information:
Title
pain numeric rating scale (NRS, 0-10)pain score at activity at 12 hours after surgery
Time Frame
At 12hours after the surgery
Secondary Outcome Measure Information:
Title
The pain scores at rest determined by the numeric rating scale (NRS, 0-10)
Time Frame
At 2,4, 8, 12,24 ,48,72hours after the surgery
Title
incidence of postoperative nausea and vomiting (PONV)
Time Frame
within 24 postoperative hours
Title
ambulation time
Time Frame
within5 days after surgery
Title
time of restart anal exhaust
Time Frame
within 5 days after surgery
Title
Postoperative length of hospital stay
Time Frame
up to2 weeks after surgery
Title
patient's satisfaction with anesthesia and analgesia
Description
use the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia and analgesia
Time Frame
48 hours after surgery
Title
The pain scores at activity determined by the numeric rating scale (NRS, 0-10)
Time Frame
At 2,4, 8, 24 ,48,72hours after the surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18-70 yrs
American Society of Anesthesiologists physical statusⅠ-Ⅲ
Undergo laparoscopic adrenalectomy
Informed consent
Exclusion Criteria:
A known allergy to the drugs being used
Coagulopathy, on anticoagulants
Analgesics intake, history of substance abuse
Participating in the investigation of another experimental agent
Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xulei CUI, md
Organizational Affiliation
Peking Union Medical College Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Peking Union Medical College Hospital
City
Beijing
Country
China
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Adrenalectomy
We'll reach out to this number within 24 hrs